Researchers from the Hospital del Mar Research Institute and the Vall d'Hebron Institute of Oncology have demonstrated, in animal models, the role played by these cells in the development of cancer cells. The study, published in Science Advances, shows that eliminating these cells at an early stage of tumor growth promotes tumor proliferation and the formation of metastases. By contrast, combining their elimination with an inhibitor of the CCL2 molecule reduces tumor size and eliminates metastases.
December 16th, 2025
It aims to develop the first treatment based on mRNA therapy to boost the efficacy of immunotherapy for this type of tumour. The new company, a spin-off of the Hospital del Mar Research Institute Barcelona, plans to launch its first human clinical trial in 2028 to validate the safety of this approach. The project is led by Drs. Toni Celià-Terrassa and Joan Albanell, pioneers in the development of nanotherapies designed to transform tumours that are resistant to immunotherapy into tumours that are vulnerable to treatment.
December 16th, 2025
These are some of the conclusions of the report "Working on digital platforms: What do we know about health and safety?", a joint study by UPF and the Hospital del Mar Research Institute Barcelona, within the framework of the international project GIG-OSH, which has collected data from seven European countries.
28 de enero de 2026
6 de febrero de 2026
3 de febrero de 2026
Parc Salut Mar
Passeig Marítim 25-29 Barcelona 08003
See location on Google maps
Phone: 93 248 30 00 · Fax: 93 248 32 54
Information request
© 2006 - 2026 Hospital del Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility
